← Back to Search

Resistance Training for Cerebral Palsy (RIPT Trial)

N/A

Recruiting

Led By Elizabeth Condliffe

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

17 years old or younger

At least 8 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 weeks (from time of consent to end of trial).

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to investigate if a specialized power training program called RIPT can help improve the motor function of youth with Cerebral Palsy. This program is not currently available in Calgary but will be

Who is the study for?

This trial is for young people with Cerebral Palsy, aged 8 to 17 years old, who can understand English and are capable of exerting maximum effort in physical activities. It's not suitable for those who don't meet these age or communication requirements.

What is being tested?

The study tests a Resistance Intensive Personal Training program designed to improve muscle strength and motor function in youth with CP. The effectiveness and feasibility of delivering this training through a community-hospital partnership are being evaluated.

What are the potential side effects?

While specific side effects aren't listed, resistance training may cause muscle soreness, fatigue, or discomfort especially when starting a new exercise regimen. Close monitoring will ensure safety for participants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 17 years old or younger.

Select...

I am at least 8 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 weeks (from time of consent to end of trial).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 weeks (from time of consent to end of trial).

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 weeks (from time of consent to end of trial). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Canadian Occupational Performance Measure

Goal Attainment Scale

Secondary study objectives

EQ-5D-Y

Gross Motor Function Measure

Muscle power assessment

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Resistance Intensive Personal Training (RIPT)Experimental Treatment1 Intervention

All participants will participate in this arm involving 12 weeks of training 2-3 days/week in a group setting with each session involving 1:1 support for each participant's power training.

0 / 2Eligibility criteria met